4.2 Article

Perspectives of mitochondrial medicine

期刊

BIOCHEMISTRY-MOSCOW
卷 78, 期 9, 页码 979-990

出版社

MAIK NAUKA/INTERPERIODICA/SPRINGER
DOI: 10.1134/S0006297913090034

关键词

mitochondria; mitochondrial diseases; mitochondrial DNA; membrane potential; mitochondrial quality control; mitochondria-targeted antioxidants; bacteria; phenoptosis

资金

  1. Russian Foundation for Basic Research [1-04-01307, 12-04-00025, 11-04-00771, 13-04-00484]
  2. Russian Federation [MK-729.2012.4]

向作者/读者索取更多资源

Mitochondrial medicine was established more than 50 years ago after discovery of the very first pathology caused by impaired mitochondria. Since then, more than 100 mitochondrial pathologies have been discovered. However, the number may be significantly higher if we interpret the term mitochondrial medicine more widely and include in these pathologies not only those determined by the genetic apparatus of the nucleus and mitochondria, but also acquired mitochondrial defects of non-genetic nature. Now the main problems of mitochondriology arise from methodology, this being due to studies of mitochondrial activities under different models and conditions that are far from the functioning of mitochondria in a cell, organ, or organism. Controversial behavior of mitochondria (friends and foes) to some extent might be explained by their bacterial origin with possible preservation of egoistic features peculiar to bacteria. Apparently, for normal mitochondrial functioning it is essential to maintain homeostasis of a number of mitochondrial elements such as mitochondrial DNA structure, membrane potential, and the system of mitochondrial quality control. Abrogation of these elements can cause a number of pathologies that have become subjects of mitochondrial medicine. Some approaches to therapy of mitochondrial pathologies are discussed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据